News Amazon Web Services, Montgomery College, George Mason University Announce the College’s First Bachelor’s Degree for Cloud Computing – MC News Montgomery College and George Mason University (Mason), in collaboration with AWS Educate, will partner to create a Bachelor of Applied Science…Super UserMarch 9, 2020
News Innovationeering: What’s your (innovation) number? In this age of near-exclusive reliance on electronic communication, practically nobody asks for your number any longer — we just…Super UserMarch 9, 2020
News Baltimore: poised for a revolution in health business | COMMENTARY – Baltimore Sun The region’s politicians and business leaders are mourning the fact Baltimore stands to lose another headquarters of a prestigious, publicly…Super UserMarch 9, 2020
News STAT Madness has begun. Vote for the best innovations in biomedicine – STAT This is our fourth annual STAT Madness, a bracket-style tournament to find the best innovations in science and medicine. The…Super UserMarch 9, 2020
News Deals News: Thermo Fisher Scientific to Buy Qiagen for $12 Bln – Bloomberg U.S. laboratory equipment maker Thermo Fisher Scientific Inc. agreed to buy Qiagen NV, a Dutch maker of tests for diseases…Super UserMarch 9, 2020
News How to Conquer Coronavirus: Top 35 Treatments in Development As the world scrambles to monitor and contain the COVID-19 outbreak, drug companies are racing to develop or repurpose treatments…Super UserMarch 9, 2020
News Innate Pharma Tomorrow and every day, we recognize the hashtag#RareDisease community on behalf of the Innate Pharma team. We do what we…Super UserMarch 9, 2020
News Immunomic Therapeutics Announces Completion of Pre-IND Meeting with US FDA for ITI-1001, a Vaccine for the Treatment of GBM – Bloomberg Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…Super UserMarch 9, 2020
News CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson’s Disease | Business Wire NEURALY ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF NLY01 FOR PATIENTS WITH PARKINSON’S DISEASE Novel Mechanism of…Super UserMarch 9, 2020
News What’s Behind Novavax’s Coronavirus/COVID-19 Vaccine Development Program · BioBuzz The BioHealth Capital Region (BHCR) has a long history of leading the fight against new, frightening diseases, like Ebola and…Super UserMarch 9, 2020